Peter B. Ehmer

714 total citations
12 papers, 584 citations indexed

About

Peter B. Ehmer is a scholar working on Pharmacology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter B. Ehmer has authored 12 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter B. Ehmer's work include Pharmacogenetics and Drug Metabolism (8 papers), Prostate Cancer Treatment and Research (4 papers) and Hormonal and reproductive studies (3 papers). Peter B. Ehmer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Prostate Cancer Treatment and Research (4 papers) and Hormonal and reproductive studies (3 papers). Peter B. Ehmer collaborates with scholars based in Germany, United States and Belgium. Peter B. Ehmer's co-authors include Rolf W. Hartmann, Joachim Jose, Samer Haidar, Ursula Müller, Christine Batzl‐Hartmann, Rita Bernhardt, Matthias Bureik, Sucharit Bhakdi, Gerd Häfner and Michael Loos and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Annals of Oncology.

In The Last Decade

Peter B. Ehmer

12 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter B. Ehmer Germany 8 232 178 176 173 99 12 584
Lina Yin China 21 234 1.0× 204 1.1× 310 1.8× 152 0.9× 143 1.4× 37 1.0k
Karsten Denner Germany 11 208 0.9× 169 0.9× 323 1.8× 70 0.4× 93 0.9× 19 660
Jian‐Ke Tie United States 19 263 1.1× 301 1.7× 264 1.5× 32 0.2× 49 0.5× 41 978
Hong Lou United States 15 90 0.4× 47 0.3× 356 2.0× 86 0.5× 78 0.8× 31 857
S. Elaine Barrie United Kingdom 16 362 1.6× 183 1.0× 564 3.2× 265 1.5× 564 5.7× 25 1.3k
E Coëzy France 11 104 0.4× 88 0.5× 262 1.5× 308 1.8× 22 0.2× 21 606
John H. Kinner United States 4 63 0.3× 68 0.4× 217 1.2× 72 0.4× 35 0.4× 6 722
Mary A. Root United States 17 253 1.1× 69 0.4× 301 1.7× 137 0.8× 60 0.6× 40 963
Tadas S. Vasaitis United States 19 307 1.3× 159 0.9× 525 3.0× 384 2.2× 445 4.5× 21 1.1k
Naoaki Murao Japan 15 59 0.3× 56 0.3× 205 1.2× 63 0.4× 21 0.2× 26 624

Countries citing papers authored by Peter B. Ehmer

Since Specialization
Citations

This map shows the geographic impact of Peter B. Ehmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Ehmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Ehmer more than expected).

Fields of papers citing papers by Peter B. Ehmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter B. Ehmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Ehmer. The network helps show where Peter B. Ehmer may publish in the future.

Co-authorship network of co-authors of Peter B. Ehmer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter B. Ehmer. A scholar is included among the top collaborators of Peter B. Ehmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter B. Ehmer. Peter B. Ehmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Calvo, Emiliano, Philippe Aftimos, Maria J. de Miguel, et al.. (2018). First-in-human, first-in-class study of the CD44v6 inhibitor AMC303 as monotherapy in patients with advanced epithelial tumors. Annals of Oncology. 29. viii134–viii134. 2 indexed citations
2.
3.
4.
5.
Haidar, Samer, et al.. (2003). Effects of novel 17α-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 84(5). 555–562. 81 indexed citations
6.
Hartmann, Rolf W., Ursula Müller, & Peter B. Ehmer. (2003). Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis. European Journal of Medicinal Chemistry. 38(4). 363–366. 36 indexed citations
7.
Aboul‐Enein, Hassan Y., Mohamed Hefnawy, Peter B. Ehmer, & Rolf W. Hartmann. (2003). Enantiomeric resolution of some human aldosterone synthase [CYP 11 B2] inhibitors on derivatized polysaccharide chiral stationary phases. Journal of Separation Science. 26(15-16). 1455–1458. 3 indexed citations
8.
Ehmer, Peter B., Matthias Bureik, Rita Bernhardt, Ursula Müller, & Rolf W. Hartmann. (2002). Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells. The Journal of Steroid Biochemistry and Molecular Biology. 81(2). 173–179. 70 indexed citations
9.
Hartmann, Rolf W., Peter B. Ehmer, Samer Haidar, et al.. (2002). Inhibition of CYP 17, a New Strategy for the Treatment of Prostate Cancer. Archiv der Pharmazie. 335(4). 119–128. 49 indexed citations
10.
Ehmer, Peter B., Joachim Jose, & Rolf W. Hartmann. (2000). Development of a simple and rapid assay for the evaluation of inhibitors of human 17α-hydroxylase-C17,20-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coli. The Journal of Steroid Biochemistry and Molecular Biology. 75(1). 57–63. 68 indexed citations
11.
Hartmann, Rolf W., et al.. (2000). Synthesis and Evaluation of Novel Steroidal Oxime Inhibitors of P450 17 (17α-Hydroxylase/C17−20-Lyase) and 5α-Reductase Types 1 and 2. Journal of Medicinal Chemistry. 43(22). 4266–4277. 74 indexed citations
12.
Horstick, Georg, Axel Heimann, Gerd Häfner, et al.. (1997). Intracoronary Application of C1 Esterase Inhibitor Improves Cardiac Function and Reduces Myocardial Necrosis in an Experimental Model of Ischemia and Reperfusion. Circulation. 95(3). 701–708. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lina Yin Breakdown of academic impact, for papers by Karsten Denner Breakdown of academic impact, for papers by Jian‐Ke Tie Breakdown of academic impact, for papers by Hong Lou Breakdown of academic impact, for papers by S. Elaine Barrie Breakdown of academic impact, for papers by E Coëzy Breakdown of academic impact, for papers by John H. Kinner Breakdown of academic impact, for papers by Mary A. Root Breakdown of academic impact, for papers by Tadas S. Vasaitis Breakdown of academic impact, for papers by Naoaki Murao
Rankless by CCL
2026